French National Councils and Companies Publicly Disclose Information About Interactions with French Health Care Professionals for the First Time as Required by the French Sunshine Act

more+
less-

On October 1, 2013, seven national councils representing French health care professionals posted on their publicly accessible websites information submitted by affected enterprises (i.e., companies) that produce or market medications, medical devices, biomaterials, and other therapeutic and cosmetic products about benefits granted to and agreements concluded with French health care professionals, as required by Article L. 1453.1 of the French Public Health Code (PHC).

The disclosure obligation is imposed by Article 2 of Law No. 2011-2012 Regarding the Reinforcement of the Safety of Medicinal and Health Products (known as the “Bertrand Act” or “French Sunshine Act”) as implemented by Decree no. 2013-414 Concerning the Transparency of Benefits Granted by Enterprises Producing or Marketing Sanitary and Cosmetic Products Intended for Human Use (“Implementing Decree”).

Please see full alert below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Topics:  Disclosure Requirements, EU, Healthcare, Healthcare Professionals, Sunshine Act

Published In: General Business Updates, Communications & Media Updates, Health Updates, Science, Computers & Technology Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© King & Spalding | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »